166 related articles for article (PubMed ID: 32256836)
21. Diagnostic value of single-source dual-energy spectral computed tomography in differentiating parotid gland tumors: initial results.
Li L; Zhao Y; Luo D; Yang L; Hu L; Zhao X; Wang Y; Liu W
Quant Imaging Med Surg; 2018 Jul; 8(6):588-596. PubMed ID: 30140621
[TBL] [Abstract][Full Text] [Related]
22. Quantitative Analysis and Pathological Basis of Signal Intensity on T2-Weighted MR Images in Benign and Malignant Parotid Tumors.
Wei P; Shao C; Tian M; Wu M; Wang H; Han Z; Hu H
Cancer Manag Res; 2021; 13():5423-5431. PubMed ID: 34262350
[TBL] [Abstract][Full Text] [Related]
23. Parotid Warthin's tumor: novel MR imaging score as diagnostic indicator.
Luna LP; Coffey W; Alvin MD; Shanechi AM; Sankaran N; Rodriguez EF; Naeem Z; Aygun N; Khan M
Clin Imaging; 2022 Jan; 81():9-14. PubMed ID: 34598007
[TBL] [Abstract][Full Text] [Related]
24. Differentiation of pleomorphic adenoma and Warthin's tumor of the parotid gland: ultrasonographic features.
Rong X; Zhu Q; Ji H; Li J; Huang H
Acta Radiol; 2014 Dec; 55(10):1203-9. PubMed ID: 24324278
[TBL] [Abstract][Full Text] [Related]
25. Pseudo-continuous arterial spin labeling MR images in Warthin tumors and pleomorphic adenomas of the parotid gland: qualitative and quantitative analyses and their correlation with histopathologic and DWI and dynamic contrast enhanced MRI findings.
Yamamoto T; Kimura H; Hayashi K; Imamura Y; Mori M
Neuroradiology; 2018 Aug; 60(8):803-812. PubMed ID: 29968073
[TBL] [Abstract][Full Text] [Related]
26. Histogram analysis of apparent diffusion coefficient maps for differentiating malignant from benign parotid gland tumors.
Ma G; Zhu LN; Su GY; Hu H; Qian W; Bu SS; Xu XQ; Wu FY
Eur Arch Otorhinolaryngol; 2018 Aug; 275(8):2151-2157. PubMed ID: 29961924
[TBL] [Abstract][Full Text] [Related]
27. Role of perfusion CT in the evaluation of adnexal masses.
Singla V; Prabhakar N; Khandelwal N; Sharma G; Singh T; Aggarwal N; Radhika S
J Obstet Gynaecol; 2019 Feb; 39(2):218-223. PubMed ID: 30257605
[TBL] [Abstract][Full Text] [Related]
28. Perfusion analysis of benign parotid gland tumors by contrast-enhanced ultrasonography (CEUS).
Welkoborsky HJ; Albers M; Küstermeyer J
Eur Arch Otorhinolaryngol; 2022 Aug; 279(8):4137-4146. PubMed ID: 35230508
[TBL] [Abstract][Full Text] [Related]
29. Differentiation of pleomorphic adenoma and Warthin's tumour of the salivary gland: is long-to-short diameter ratio a useful parameter?
Miao LY; Xue H; Ge HY; Wang JR; Jia JW; Cui LG
Clin Radiol; 2015 Nov; 70(11):1212-9. PubMed ID: 26216455
[TBL] [Abstract][Full Text] [Related]
30. Parotid pleomorphic adenomas: delayed CT enhancement.
Lev MH; Khanduja K; Morris PP; Curtin HD
AJNR Am J Neuroradiol; 1998; 19(10):1835-9. PubMed ID: 9874532
[TBL] [Abstract][Full Text] [Related]
31. Parotid tumors: differentiation of benign and malignant tumors with quantitative sonographic analyses.
Yonetsu K; Ohki M; Kumazawa S; Eida S; Sumi M; Nakamura T
Ultrasound Med Biol; 2004 May; 30(5):567-74. PubMed ID: 15183220
[TBL] [Abstract][Full Text] [Related]
32. Multiparametric approach with synthetic MR imaging for diagnosing salivary gland lesions.
Takumi K; Nakanosono R; Nagano H; Hakamada H; Kanzaki F; Kamimura K; Nakajo M; Eizuru Y; Nagano H; Yoshiura T
Jpn J Radiol; 2024 May; ():. PubMed ID: 38733471
[TBL] [Abstract][Full Text] [Related]
33. Fluorine-18 fluorodeoxyglucose positron emission tomography imaging of parotid mass lesions.
Okamura T; Kawabe J; Koyama K; Ochi H; Yamada R; Sakamoto H; Matsuda M; Ohashi Y; Nakai Y
Acta Otolaryngol Suppl; 1998; 538():209-13. PubMed ID: 9879423
[TBL] [Abstract][Full Text] [Related]
34. Proliferative activity as detected by immunostaining with Ki-67 and proliferating cell nuclear antigen in benign and malignant epithelial lesions of the human parotid gland.
Zhu Q; Tipoe GL; White FH
Anal Quant Cytol Histol; 1999 Aug; 21(4):336-42. PubMed ID: 10560511
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic value of metabolic heterogeneity as a reliable parameter for differentiating malignant parotid gland tumors.
Kim BS; Kim SJ; Pak K
Ann Nucl Med; 2016 Jun; 30(5):346-54. PubMed ID: 26897010
[TBL] [Abstract][Full Text] [Related]
36. Value of diffusion tensor imaging in differentiating malignant from benign parotid gland tumors.
Takumi K; Fukukura Y; Hakamada H; Ideue J; Kumagae Y; Yoshiura T
Eur J Radiol; 2017 Oct; 95():249-256. PubMed ID: 28987676
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of MR imaging findings differentiating parotid basal cell adenomas from other parotid tumors.
Murayama Y; Kamitani T; Sagiyama K; Yamasaki Y; Hida T; Matsuura Y; Yasumatsu R; Yamamoto H; Yabuuchi H; Ishigami K
Eur J Radiol; 2021 Nov; 144():109980. PubMed ID: 34601323
[TBL] [Abstract][Full Text] [Related]
38. Differential diagnostic value of computed tomography perfusion combined with vascular endothelial growth factor expression in head and neck lesions.
Wang J; Tang Z; Wang S; Zeng W; Qian W; Wu L; Wang W; Luo J
Oncol Lett; 2016 May; 11(5):3342-3348. PubMed ID: 27123114
[TBL] [Abstract][Full Text] [Related]
39. Warthin's tumor distribution within the parotid gland. A feasible etiologic source from lymph nodal tissue.
Colella G; Biondi P; Itro A; Compilato D; Campisi G
Minerva Stomatol; 2010 May; 59(5):245-9, 250-2. PubMed ID: 20502429
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic value of FDG PET and salivary gland scintigraphy for parotid tumors.
Uchida Y; Minoshima S; Kawata T; Motoori K; Nakano K; Kazama T; Uno T; Okamoto Y; Ito H
Clin Nucl Med; 2005 Mar; 30(3):170-6. PubMed ID: 15722820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
